Dual Endothelin Antagonist:
Evaluating Aprocitentan for Hypertension
A Review of Phase 2 and Phase 3 Clinical Trial Data

  1. If you would like to request any additional information, please contact Idorsia Medical Information by completing the medical inquiry form found here.
US Consumer (e.g., patient) US Healthcare Professional